With Rituximab, B-cell Counts Predict COVID Vaccine Response & Everything Takes So Long With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how among MS patients on rituximab, higher immune B-cell counts are predictive of a better antibody-based response to a COVID-19 vaccine.

He also reads “No Crisis, No Column? OK, Fine: Everything Takes So Long With MS” from John Connor's column, "Fall Down, Get Up Again."
===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/